<DOC>
	<DOCNO>NCT00933023</DOCNO>
	<brief_summary>Topical steroid use treatment non-retractile foreskin child decade , , disagreement among physician optimum potency agent use . This study design determine difference beneficial effect mild versus potent topical corticosteroid treatment non-retractile foreskin child .</brief_summary>
	<brief_title>Mild Versus Potent Corticosteroids Treatment Phimosis Children</brief_title>
	<detailed_description />
	<mesh_term>Phimosis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Children 216 nonretractile foreskin Balanitis xerotica obliterans , balanitis , &lt; 2yrs</criteria>
	<gender>Male</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>